Medical and Pharmacy Drug Management

Latest Resource

Medical and Pharmacy Drug Management Resources

A summary of the latest National Alliance resources.

The National Alliance PBM Misalignment Initiative investigates and addresses misalignment between employers and their pharmacy benefit management (PBM) service providers.  Building on the 2023 PBM Playbook and other related resources, this final report […]

The following one-page resources on 340B, PBM reform, combating high and rising hospital prices, were presented during the National Alliance Hill visits in November 2024.

The National Alliance is continuously exploring how misalignment between employer needs and PBM service provider value propositions have affected employers and other and plan sponsors. There is growing risk for […]

As the pharmacy benefit management industry undergoes the most significant transformation in decades, employers are at the forefront of driving change. This vendor engagement template equips them with information to […]

The Pulse of the Purchaser study gauges concerns and approaches of employers to address the workforce environment; whole person health, equity, women’s health, mental health and obesity management; fiduciary perspectives; pharmaceutical […]

Coalitions In Action

Membership in the National Alliance is a catalyst for state and regional coalitions and their employer/purchaser members to advance key initiatives. Together, they leverage their collective influence to drive health, equity and value.

Pharmacy and Medical Drugs

Defining and Driving Value

The National Alliance works with policymakers, employers/purchasers, and other stakeholders across the pharmacy and medical drug supply chain to influence competition, transparency, and value. Current issues of focus include pharmacy benefit manager (PBM) performance, contracting and formulary management, biosimilars, reducing waste, pharmacogenomics, and value-based benefit design.

The initiatives focus on practices affecting both pharmacy and medical benefits, with a strong emphasis on the rising costs of healthcare, hospital pricing, and prescription drugs. For example, the National Alliance has recently been engaging with policymakers to provide insights on the 340B program, its impact on escalating healthcare expenses for working families and employers, and potential areas for reform.

Explore these additional resources for a deeper look at the 340B program’s impact on healthcare costs and reform initiatives.